IP Library › Granted Patent US 12,371,677
Granted Patent B2
US 12,371,677 · App. 18/525,234 · Granted Jul 29, 2025

UDP-dependent glycosyltransferase for high efficiency production of rebaudiosides

Inventors: Lishan Zhao (Emeryville, CA); Wenzong Li (Emeryville, CA); Gale Wichmann (Berkeley, CA); Aditi Khankhoje (Emeryville, CA); Chantal Garcia De Gonzalo (Richmond, CA); Tina Mahatdejkul-Meadows (Milpitas, CA); Shaina Jackson (Oakland, CA); Michael Leavell (Richmond, CA); Darren Platt (San Francisco, CA)
Assignee: Corn Products Development, Inc.
C12N9/1051A23L2/60A23L27/36C12N15/52C12N15/81C12P19/18C12P19/56C12Y204/01017A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,371,677
App. No.
18/525,234
Granted
Jul 29, 2025
Kind
B2
Abstract

Provided herein are compositions and methods for improved production of steviol glycosides in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a Setaria italica UDP-glycosyltransferase 40087 or its variant UDP-glycosyltransferase. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a UDP-glycosyltransferase sr.UGT_9252778, Bd_UGT10850, and/or Ob_UGT91B1_like. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing steviol glycosides in the host cell. The compositions and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M.

Claims (18)

1. A genetically modified yeast host cell comprising a heterologous nucleic acid encoding a UDP-glycosyltransferase comprising an amino acid sequence having at least 80% sequence identity to SEQ ID NO: 6, wherein the genetically modified host cell is capable of converting Rebaudioside A (RebA) to Rebaudioside D (RebD) at an efficiency of greater than 90%.

2. The genetically modified host cell of claim 1 , wherein the UDP-glycosyltransferase comprises an amino acid sequence having the sequence of SEQ ID NO: 6.

3. The genetically modified host cell of claim 1 , wherein the UDP-glycosyltransferase is capable of beta 1,2 glycosylation of the C2 position of the 19-O glucose of a steviol glycoside.

4. The genetically modified host cell of claim 1 , that is capable of converting RebA to RebD at an efficiency of greater than 90% and wherein the UDP-glycosyltransferase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 6.

5. The genetically modified host cell of claim 1 , wherein the UDP-glycosyltransferase comprises an amino acid sequence having at least 92% sequence identity to SEQ ID NO: 6.

6. The genetically modified host cell of claim 1 that is capable of producing RebD.

7. The genetically modified host cell of claim 1 that is capable of producing rebaudioside M (RebM).

8. The genetically modified host cell of claim 1 that is capable of producing at RebM and RebM2 at a ratio of at least 10:1, 100:1, or 1000:1.

9. The genetically modified host cell of claim 1 , wherein the genetically modified host cell produces an undetectable level of RebM2.

10. The genetically modified host cell of claim 1 , wherein the genetically modified host cell is capable of converting stevioside to RebE.

11. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises one or more heterologous nucleic acids encoding one or more enzymes of a pathway for making steviol.

12. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises one or more heterologous nucleic acids encoding one or more enzymes of a pathway for making a steviol glycoside.

13. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises one or more heterologous nucleic acids encoding one or more enzymes of a pathway for making a RebA.

14. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises one or more heterologous nucleic acids encoding one or more enzymes of a pathway for making RebM.

15. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises one or more heterologous nucleic acids encoding one or more enzymes of a pathway for making RebE.

16. The genetically modified host cell of claim 1 , wherein the one or more enzymes of the pathway comprise a geranylgeranyl diphosphate synthase, a copalyl diphosphate synthase, a ent-kaurene synthase, a kaurene oxidase, a kaurenoic acid hydroxylase, a cytochrome P450 reductase, UGT74G1 (SEQ ID NO: 31), UGT76G1 (SEQ ID NO: 32), UGT85C2 (SEQ ID NO: 33), and UGT91D (SEQ ID NO: 7).

17. The genetically modified host cell of claim 1 , comprising a heterologous nucleic acid encoding a UDP-glycosyltransferase comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 6.

18. The genetically modified host cell of claim 1 , comprising a heterologous nucleic acid encoding a UDP-glycosyltransferase comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 6.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2025
From: AMYRIS, INC.
To: CORN PRODUCTS DEVELOPMENT, INC.
Reel/Frame 071314/0668 →
RELEASE OF SECURITY INTEREST Recorded May 29, 2025
From: EUAGORE, LLC
To: AMYRIS, INC.
Reel/Frame 071260/0237 →
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: ZHAO, LISHAN; LI, WENZONG; WICHMANN, GALE; KHANKHOJE, ADITI; GARCIA DE GONZALO, CHANTAL; MAHATDEJKUL-MEADOWS, TINA; JACKSON, SHAINA; LEAVELL, MICHAEL; PLATT, DARREN
To: AMYRIS, INC.
Reel/Frame 065926/0876 →
Continuity (4)
Continuation 17382963 · Jul 22, 2021
Division 16323756
Provisional Application 62374408 · Aug 12, 2016
Related Publication 20240174987A1 · May 30, 2024
References Cited (129)
US 8703225B2 · Morita et al. · 2014 [cited by applicant]
US 9243273B2 · Markosyan et al. · 2016 [cited by applicant]
US 9284570B2 · Stephanopoulos · 2016 [cited by examiner]
US 9562251B2 · Kishore et al. · 2017 [cited by applicant]
US 9631215B2 · Houghton-Larsen et al. · 2017 [cited by applicant]
US 9752174B2 · Markosyan · 2017 [cited by applicant]
US 9848632B2 · Morita et al. · 2017 [cited by applicant]
US 9957540B2 · Mikkelsen et al. · 2018 [cited by applicant]
US 10000783B2 · Ono et al. · 2018 [cited by applicant]
US 10017804B2 · Simon et al. · 2018 [cited by applicant]
US 10113154B2 · Ono · 2018 [cited by applicant]
US 10113155B2 · Ono · 2018 [cited by applicant]
US 10364450B2 · Olsson et al. · 2019 [cited by applicant]
US 10392644B2 · Kishore et al. · 2019 [cited by applicant]
US 10420360B2 · Morita et al. · 2019 [cited by applicant]
US 10421983B2 · Douchin et al. · 2019 [cited by applicant]
US 10442831B2 · Mao et al. · 2019 [cited by applicant]
US 10450338B2 · Mao et al. · 2019 [cited by applicant]
US 10472660B2 · Park et al. · 2019 [cited by applicant]
US 10485257B2 · Markosyan et al. · 2019 [cited by applicant]
US 10499661B2 · Purkayastha et al. · 2019 [cited by applicant]
US 10612065B2 · Anderson et al. · 2020 [cited by applicant]
US 10774103B2 · Mao et al. · 2020 [cited by applicant]
US 10800803B2 · Mao et al. · 2020 [cited by applicant]
US 10815513B2 · Anderson et al. · 2020 [cited by applicant]
US 10815514B2 · Olsson et al. · 2020 [cited by applicant]
US 10888099B2 · Purkayastha et al. · 2021 [cited by applicant]
US 11091743B2 · Zhao et al. · 2021 [cited by applicant]
US 11866738B2 · Zhao · 2024 [cited by examiner]
US 20160021918A1 · Brower, III et al. · 2016 [cited by applicant]
US 20180371003A1 · Geertman et al. · 2018 [cited by applicant]
US 20180371516A1 · Geertman et al. · 2018 [cited by applicant]
US 20180371517A1 · Simon et al. · 2018 [cited by applicant]
US 20190062796A1 · Dyekjaer et al. · 2019 [cited by applicant]
US 20190144907A1 · Hansen et al. · 2019 [cited by applicant]
US 20190194240A1 · Galaev et al. · 2019 [cited by applicant]
US 20190203245A1 · Douchin et al. · 2019 [cited by applicant]
US 20190270971A1 · Donald et al. · 2019 [cited by applicant]
US 20200017896A1 · Olsson et al. · 2020 [cited by applicant]
US 20200024630A1 · Douchin et al. · 2020 [cited by applicant]
US 20200032227A1 · Vroom et al. · 2020 [cited by applicant]
US 20200080123A1 · Heal et al. · 2020 [cited by applicant]
US 20200123583A1 · Houghton-Larsen et al. · 2020 [cited by applicant]
US 20200157594A1 · Markosyan et al. · 2020 [cited by applicant]
US 20200165651A1 · Wichmann et al. · 2020 [cited by applicant]
US 20200221746A1 · Markosyan et al. · 2020 [cited by applicant]
US 20200283814A1 · Anderson et al. · 2020 [cited by applicant]
US 20200283815A1 · Boer et al. · 2020 [cited by applicant]
US 20200283816A1 · Boer et al. · 2020 [cited by applicant]
US 20200308617A1 · Mikkelsen et al. · 2020 [cited by applicant]
US 20200347425A1 · Philippe et al. · 2020 [cited by applicant]
US 20210009968A1 · Donald et al. · 2021 [cited by applicant]
US 20210037864A1 · Morita et al. · 2021 [cited by applicant]
AU 2013211605B2 · 2017 [cited by applicant]
AU 2016271628B2 · 2020 [cited by applicant]
AU 2019264515B2 · 2021 [cited by applicant]
CN 104726523A · 2015 [cited by applicant]
EP 2954058B1 · 2014 [cited by applicant]
EP 2826861A1 · 2015 [cited by applicant]
EP 2350110B1 · 2016 [cited by applicant]
EP 2742142B2 · 2016 [cited by applicant]
EP 3101023A1 · 2016 [cited by applicant]
EP 2963122B1 · 2018 [cited by applicant]
EP 2498625B1 · 2018 [cited by applicant]
EP 2806754B1 · 2018 [cited by applicant]
EP 2862927B1 · 2018 [cited by applicant]
EP 3004366B1 · 2019 [cited by applicant]
EP 3461342A1 · 2019 [cited by applicant]
EP 3502264A2 · 2019 [cited by applicant]
EP 2575432B1 · 2019 [cited by applicant]
EP 3593633A1 · 2020 [cited by applicant]
EP 2832858B1 · 2020 [cited by applicant]
EP 3683315A1 · 2020 [cited by applicant]
EP 3009508B1 · 2020 [cited by applicant]
WO WO2013022989A2 · 2013 [cited by applicant]
WO WO2013176738A1 · 2013 [cited by applicant]
WO WO2014122227A2 · 2014 [cited by applicant]
WO WO2014122328A1 · 2014 [cited by applicant]
WO WO2014193888A1 · 2014 [cited by applicant]
WO WO2015007748A1 · 2015 [cited by applicant]
WO WO2016023844A1 · 2016 [cited by applicant]
WO WO2016038095A2 · 2016 [cited by applicant]
WO WO2016073740A1 · 2016 [cited by applicant]
WO WO2016120486A1 · 2016 [cited by applicant]
WO WO2016196321A1 · 2016 [cited by applicant]
WO WO2016196345A1 · 2016 [cited by applicant]
WO WO2017009293A1 · 2017 [cited by applicant]
WO WO2017009294A1 · 2017 [cited by applicant]
WO WO2017025649A1 · 2017 [cited by applicant]
WO WO2017098017A1 · 2017 [cited by applicant]
WO WO2017178632A1 · 2017 [cited by applicant]
WO WO2017198681A1 · 2017 [cited by applicant]
WO WO2017198682A1 · 2017 [cited by applicant]
WO WO2018029272A1 · 2018 [cited by applicant]
WO WO2018083338A1 · 2018 [cited by applicant]
WO WO2018213279A1 · 2018 [cited by applicant]
WO WO19193356A1 · 2019 [cited by applicant]
WO WO19211230A1 · 2019 [cited by applicant]
Bennetzen et al., Reference genome sequence of the model plant Setaria. Nature Biotechnol., 2012, vol. 30(6): 555-561. [cited by applicant]
Broun et al., Catalytic plasticity of fatty acid modification enzymes underlying chemical diversity of plant lipids. Science, 1998, vol. 282: 1315-1317. [cited by applicant]
Ceunen et al., “Steviol Glycosides: Chemical Diversity, Metabolism, and Function”, J. Nat. Prod., 2013, vol. 76, No. 6, pp. 1201-1228. [cited by applicant]
Database RefSeq [Online] Nov. 30, 2015, “UDP-glycosyltransferase 91A1 [Setaria italica]”, XP002775106, 1 page. [cited by applicant]
Devos et al., Practical limits of function prediction. Proteins: Structure, Function, and Genetics, 2000, vol. 41, pp. 98-107. [cited by applicant]
GenBank: AAQ63464.1, Jun. 21, 2006; 2 pages. [cited by applicant]
GenBank: AAR06912.1, Dec. 28, 2004; 1page. [cited by applicant]
GenBank: AAR06916.1, Dec. 28, 2004; 2 pages. [cited by applicant]
GenBank: AAR06920.1, Dec. 28, 2004; 2 pages. [cited by applicant]
GenBank: ABC47946.1, Apr. 13, 2006; 2 pages. [cited by applicant]
GenBank: ACE87855.1, Jun. 24, 2008; 2 pages. [cited by applicant]
GenBank: ADB55711.1, Mar. 9, 2010; 2 pages. [cited by applicant]
GenBank: AFC92798.1, Dec. 21, 2012; 2 pages. [cited by applicant]
GenBank: BAJ94055.1, May 20, 2011; 2 pages. [cited by applicant]
Griggs & Johnston, “Regulatedexpressionof the GAL4 activator gene in yeast provides asensitive genetic switch for glucose repression”, Proc. Natl. Acad. Sci. USA, Oct. 1991, vol. 88, pp. 8597-8601. [cited by applicant]
Guo et al., Protein tolerance to random amino acid change. PNAS., 2004, vol. 101 (25): 9205-9210. (Year: 2004). [cited by applicant]
International Search report and written opinion mailed on Feb. 8, 2018 for PCT/US2017/046637, 29 pages. [cited by applicant]
NCBI Reference Sequence: XP_003560669.1, Mar. 27, 2018; 2 pages. [cited by applicant]
NCBI Reference Sequence: XP_004250485.1, Aug. 8, 2018; 2 pages. [cited by applicant]
NCBI Reference Sequence: XP_004982059.1, Oct. 13, 2017; 2 pages. [cited by applicant]
NCBI Reference Sequence: XP_006650455.1, Mar. 4, 2016; 2 pages. [cited by applicant]
NCBI Reference Sequence: XP_010230871.1, Mar. 27, 2018; 2 pages. [cited by applicant]
NCBI Reference Sequence: XP_015629141.1, Aug. 7, 2018; 2 pages. [cited by applicant]
Ohta et al., “Characterization of Novel Steviol Glycosides from Leaves of [cited by applicant]
Prakash et al., “Development of Next Generation Stevia Sweetener: Rebaudioside M”, Foods, vol. 3, No. 1, Feb. 27, 2014, pp. 162-175. [cited by applicant]
“Predicted: Setaria italica UDP-glycosyltransferase 91A1-like (LOC101782527), mRNA” [Nov. 30, 2015] Retrieved from GenBank [online] Accession No. XM_004982002.3 [retrieved on Jun. 1, 2021]. [cited by applicant]
Seffernick et al., Melamine deaminase and Atrazine chlorohydrolase: 98 percent identical but functionally different. J. Bacteriol., 2001, vol. 183 (8): 2405-2410. [cited by applicant]
UniProtKB, Primary accession No. K4AME6, Nov. 28, 2012; 3 pages. [cited by applicant]
Whisstock et al., Prediction of protein function from protein sequence. Q. Rev. Biophysics., 2003, vol. 36 (3): 307-340. [cited by applicant]
Witkowski et al., Conversion of b-ketoacyl synthase to a Malonyl Decarboxylase by replacement of the active cysteine with glutamine. Biochemistry, 1999, vol. 38: 11643-11650. [cited by applicant]
NCBI Reference Sequence: XP_004982120.2, “Predicted: UDP-glycosyltransferase 91D1-like [Setaria italica]”, Nov. 30, 2015. [cited by applicant]